Finally, a Dr. Oz Show That I Really Want to Watch July

New Post Public Reply Private Reply Replies (0) Message Board
Bhawks
228
Finally, a Dr. Oz Show That I Really Want to Watch
July 28, 2022



Credit...Ben Wiseman
By Frank Bruni

Mr. Bruni is a contributing Opinion writer who was on the staff of The Times for more than 25 years.

https://www.nytimes.com/2022/07/28/opinion/dr...enate.html

I must have watched a few whole episodes of “The Dr. Oz Show” when I wrote a long profile of Mehmet Oz for The Times Magazine back in 2010, but afterward? Please. I’m a glutton, but not for punishment, and the snippets of the show that I’d happen upon convinced me that snippets sufficed.

Oz was more huckster than healer, more showman than shaman, grinning dopily as he sacrificed his integrity on the altar of ratings. I encountered enough Faustian parables of that ilk as a journalist covering politics. I didn’t need them in my daytime television.

But I’m enthralled by Oz’s newest production, by which I mean his campaign for the Senate. It may be my favorite Senate race ever.

By “favorite” I don’t mean that it inspires me, at least not to anything but disputably clever prose. I mean that it has such a surfeit of unlikely details, such a concentration of modern political themes.

Such enormous stakes, too. While Republicans are very likely to win back the House in November 2022, thanks to the normal midterm pendulum swing and voters’ profound economic anxiety, Democrats have a real chance to hold on to the Senate, and their fate probably rests on a few key contests, including the one in Pennsylvania between Oz, the Republican nominee, and John Fetterman, his Democratic rival. They’re vying for the seat being vacated by Senator Pat Toomey, a Republican who’s retiring.

You couldn’t script a matchup like this. Oz, an accomplished surgeon, has spent decades enshrining himself as a trim, taut, manically energetic paradigm of peak health; I sometimes look at him and just see a big bowl of leafy greens and ancient grains dressed with low-fat yogurt. I look at Fetterman and see a sausage pizza. (I think I mean that as a compliment.)

Fetterman, the lieutenant governor of Pennsylvania, suffered a stroke just days before the Democratic primary in May and spent the next two months off the campaign trail, in recovery.

He said recently that his hearing still isn’t what it used to be. He also disclosed that he’d been diagnosed with an irregular heartbeat in 2017 but hadn’t faithfully taken his prescribed medication or even returned to the doctor over the next five years.

So it’s the health truant versus the health tyrant.

But it’s also the television wizard versus the Twitter wiseacre. Oz knows how to woo and wow a small-screen audience, but, as the subhead of an excellent recent article by Matthew Cantor in The Guardian noted, Fetterman “is wielding social media might against star power.”

The Fetterman campaign operates in extreme meme mode, trolling Oz in particular for being a New Jerseyan in unpersuasive Pennsylvania drag. It deconstructed the décor in an Oz campaign video to show that he was speaking from a room in his New Jersey manse. It hired the “Jersey Shore” star Nicole (Snooki) Polizzi to beckon Oz home in a video clip that got more than three million views on Twitter.

It followed that inspired mischief with a video in which another recognizable ambassador for New Jersey — the guitarist Steven Van Zandt, who plays in Bruce Springsteen’s E Street Band and had a role in “The Sopranos” — cautions Oz about his Pennsylvania misadventure.

But the most devastating recent Oz taunt came from outside the Fetterman campaign, in the form of an ad that documented the doctor’s recurring promotion of bogus miracle cures and used footage from “The Wizard of Oz” to shame him for it.

Dorothy, Toto and the gang never performed a nobler service.
Oz is off. He responded to the sneak Snooki attack with a cringe-inducing game of famous-acquaintance one-upmanship. “She’s been on my show,” he told Dom Giordano, a Philadelphia talk-radio host. “I know all these celebrities. I could actually have celebrities do my campaign for me.”

Take that, John Fetterman! You may have a consistent political ideology. Oz has been to the Emmys.

Therein lies a Republican predicament. With Oz in Pennsylvania, Herschel Walker in Georgia and, to a lesser extent, J.D. Vance in Ohio, the party has nominated Senate candidates whose star statuses aren’t paired with comparable political acumen and whose flaws or fumbles have given their Democratic counterparts a better chance than they might have had against more experienced, more traditional candidates.
Fame is funny that way.


It can be redeemed for many things but not for everything. And the blessing of Donald Trump — which Oz, Vance and Walker all received — is funny, too. It giveth in the primary only to taketh away in the general, or at least (fingers crossed) that’s a distinct possibility.

Despite Fetterman’s stroke and convalescence, he has been raising much more money than Oz has. He was more than five points ahead of Oz in two June polls. The National Review columnist Jim Geraghty called Oz “the wildly underperforming Ford Pinto of Republican Senate candidates.”

Not even a Tesla in vain search of a charging station? Whatever the beleaguered vehicle’s make and model, I can’t take my eyes off this car wreck.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AEVEX Faces $100K+ Losses in New Investor Lawsuit

Updated Category News Views 1

When the suits start flying, folks, you know there's a mess brewing somewhere in the market. Here we are, talking about AEVEX Corp, ticker NYSE:AVEX, and they’re facing some serious heat. There's some scuttlebutt about a class action lawsuit that’s got investors clutching onto their wallets tighter than ever. If you’ve been scouring over the papers, this lawsuit is...

Continue Reading
Morpho Unveils Versatile UV Printer at IFA 2026

Updated Category News Views 0

IFA 2026: A New Frontier for Desktop Printing You've seen your fair share of printers over the years, but when a company like Morpho steps onto the scene with a gadget that echoes innovation, it makes you perk up those market-ears. We're talking the big unveil of their desktop UV printer at the IFA 2026 in Berlin. Morpho's contraption isn't just spewing out ink; it's...

Continue Reading
LiberNovo Demos Ergonomic Seating at IFA 2026

Updated Category News Views 0

Riding the Ergonomic Wave at IFA 2026 No stranger to the innovation spotlight, LiberNovo’s got its eyes on Berlin this time around. As sparks fly at the IFA 2026, they’re rolling out their grand Maxis Series and rubbing shoulders with big names in technology. How does a company shake things up in a sea of tech? Start by thinking big and tall—literally. Maxis Series:...

Continue Reading
Postal Service Defends New Rule Amid Speculation

Updated Category News Views 3

USPS Navigates Election Mail Controversies The U.S. Postal Service has found itself in the eye of a political storm, thanks to the latest Federal Ballot Mail Rule. Led by Postmaster General David Steiner, the USPS is setting the record straight amidst swirling misinformation and skepticism about its recent actions. This is not just a postal service under scrutiny—it's a...

Continue Reading
Virterion Surges Ahead in VPS Racing With Reliable Hosting

Updated Category News Views 2

Why Virterion Stands Out in 2026 VPS Landscape For anyone knee-deep in the hosting game, you know the market's got more players than a late-night poker round. Virterion, though—that's a name carving out a noticeable niche, and for solid reasons. In 2026, the backdrop's not just speed, it’s about matching technology and support with what ambitious developers need. VPS...

Continue Reading
viaim's AI Earbuds Snag IFA Awards, Launch On Indiegogo

Updated Category News Views 0

When the tech cosmos hands you two hefty IFA Innovation Awards, you know you’re onto something. viaim’s Rise wasn't just about slick marketing—it brought home the 'Best in Audio' and 'Best in Design' titles from IFA 2026, proving these earbuds are more than just another gadget. Key Innovations Behind the Accolades IFA is no small affair—it's a major tech trade...

Continue Reading
Sarepta Under Scrutiny: KSF's Investigation Deepens

Updated Category News Views 5

A Troubling Chapter for Sarepta Therapeutics It's not every day that a company's dirty laundry gets hung out for all to see, especially when we're talking about Sarepta Therapeutics, a player in the rare disease treatment space. But that's exactly where we find ourselves this fine day—a bit like kicking a hornet's nest, if you ask me. Led by the former Louisiana...

Continue Reading
ToolDance X1 CNC Mill Unveils at IFA 2026

Updated Category News Views 1

IFA 2026 Reveals a Game Changer: ToolDance X1 Listen up, because ToolDance just threw a curveball into the CNC world with the launch of their X1 Smart Desktop CNC Mill at the IFA 2026 in Berlin. This isn't just another gadget—it's a real player aiming to bring manufacturing muscle right to your desktop. Will Wang, the genius behind ToolDance, wants to democratize CNC...

Continue Reading
Tuya Smart's AI Innovations Steal the Spotlight at IFA

Updated Category News Views 2

AI Taking Center Stage at IFA 2026 Amidst the chaos of tech exhibitions, something caught my attention—Tuya Smart's push in making AI a household name. Now, you might wonder why I’m bringing this up. Well, because it's not your typical flashy gadget talk. This is about Tuya parading their latest breakthroughs like a peacock at the world's stage, IFA 2026 in Berlin,...

Continue Reading
SIAL West Asia Ignites Global F&B Trade at Guangzhou

Updated Category News Views 3

A Convergence of Global Taste You could feel the buzz in the air as the 2026 SIAL West Asia International Food Exhibition kicked off at the Guangzhou Poly World Trade Center Expo. Throw over 1,500 exhibitors from the far corners of the globe into a sprawling 60,000-square-meter trade floor, and you've got yourself a melting pot of flavors and cultures revolving around a...

Continue Reading

Top 5 Most Recently Viewed Articles

Power Metals Forms Cesium Advisory Committee and Grant News

Updated Category News Views 78

Power Metals Launches New Cesium Advisory Committee Power Metals Corp is taking significant steps in exploring critical minerals by forming a Cesium Advisory Committee. This move comes after great interest from major chemical firms worldwide in the Case Lake Project (CLP), a vital area for cesium exploration. The new committee is set to guide and improve the progress of...

Continue Reading
Foresight Enterprise VCT PLC Issues New Equity Shares

Updated Category News Views 183

Foresight Enterprise VCT PLC Issues New Ordinary Shares The Board of Foresight Enterprise VCT PLC is excited to share the news regarding the allotment of new Ordinary Shares. This move is part of a broader effort to enhance the company's capital structure and facilitate its growth strategy. Details of the Allotment Recently, 35,714 Ordinary Shares with a nominal value of...

Continue Reading
Discover the Akluer 520 Dual-Sided Treadmill for Wellness

Updated Category News Views 133

Akluer Launches the Akluer 520 Dual-Sided Treadmill Akluer, a pioneer in the fitness industry, has unveiled a remarkable innovation: the Akluer 520 Dual-Sided Treadmill. This state-of-the-art treadmill not only serves as a reliable tool for your workouts but also incorporates a unique foot massager, creating a comprehensive fitness experience in one compact design. What...

Continue Reading
Valentina Shevchenko Triumphs at UFC 315 with Unstoppable Spirit

Updated Category News Views 423

Valentina Shevchenko Defends UFC Women's Flyweight Title In an electrifying showdown, Valentina Shevchenko showcased her martial prowess at UFC 315. The iconic MMA athlete, recognized as a powerhouse in the UFC Women's Flyweight division, successfully defended her title against a formidable opponent, Manon Fiorot. Fight Overview In a highly anticipated co-main event,...

Continue Reading
Kairos Pharma Unveils Milestones and Vision for the Future

Updated Category News Views 270

Kairos Pharma Unveils Key Milestones and Future Aspirations LOS ANGELES - Kairos Pharma Ltd. (NYSE American: KAPA), a pioneering biopharmaceutical company focusing on cancer therapies, has recently shared significant achievements from 2024 and outlined their ambitious goals for 2025 in a Letter to Shareholders. Currently trading at $1.73, KAPA has seen an impressive 14.5%...

Continue Reading